
CAS 927819-64-5
:Fórmula:C31H41N3O7
InChI:InChI=1S/C31H41N3O7/c35-28(34-21-9-15-27(34)31(40)41)24(33-26(30(38)39)19-17-23-12-5-2-6-13-23)14-7-8-20-32-25(29(36)37)18-16-22-10-3-1-4-11-22/h1-6,10-13,24-27,32-33H,7-9,14-21H2,(H,36,37)(H,38,39)(H,40,41)/t24-,25?,26-,27-/m0/s1
Chave InChI:MKOWVLMGJKGFMF-MBKURTIGSA-N
SMILES:C1C[C@H](N(C1)C(=O)[C@H](CCCCNC(CCC2=CC=CC=C2)C(=O)O)N[C@@H](CCC3=CC=CC=C3)C(=O)O)C(=O)O
Filtrar por
Percentagem de pureza
0
100
|
0
|
50
|
90
|
95
|
100
Foram encontrados 5 produtos.
- Preços em ordem crescente
- Preços em ordem decrescente
- Menor grau de pureza
- Maior grau de pureza
- Estimativa de entrega mais rápida
Lisinopril EP Impurity I
CAS:Fórmula:C31H41N3O7Cor e Forma:White To Off-White SolidPeso molecular:567.68N2-((S)-1-Carboxy-3-phenylpropyl)-N6-(1-carboxy-3-phenylpropyl)-L-lysyl-L-proline
CAS:Fórmula:C31H41N3O7Pureza:97%Peso molecular:567.67N-(1-Carboxy-3-phenylpropyl)-S-lisinopril (Mixture of diastereomers)
CAS:Produto ControladoApplications N-(1-Carboxy-3-phenylpropyl)-S-lisinopril (Mixture of diastereomers) is an impurity of lisinopril (L468985), an orally active angiotensin-converting enzyme (ACE) inhibitor.
References Shinde, V., et. al.: J. Pharm. Biomed. Anal., 43, 381 (2007); Goa, K.L., et al.: Drugs, 52, 564 (1996), Chaturvedi, N., et al.: Lancet, 351, 28 (1998)Fórmula:C31H41N3O7Cor e Forma:NeatPeso molecular:567.67Lisinopril EP Impurity I
CAS:Lisinopril EP Impurity I is an impurity of the drug lisinopril. It is a natural product that has been synthesized for use as an analytical standard for pharmacological research and development. Lisinopril EP Impurity I is a synthetic compound that was custom-synthesized from amino acid derivatives and has been used in the manufacture of pharmaceuticals as an impurity standard, including as a high purity HPLC standard. This impurity has been shown to be less toxic than other lisinopril epimerization products, such as lisinopril epimerization product II, which can cause renal toxicity. Lisinopril EP Impurity I also has anti-inflammatory effects and can inhibit LPS-induced production of nitric oxide by macrophages.Fórmula:C31H41N3O7Pureza:Min. 95%Peso molecular:567.7 g/mol





